Citeline Podcasts
A podcast by Citeline
Categories:
1232 Episodes
-
【3分で解説 世界のファーマ】第22回 AD治療、費用対効果に悩む英国 (Japanese-language podcast)
Published: 10/29/2024 -
Scrip's Five Must-Know Things - 28 October 2024
Published: 10/28/2024 -
Conference Catch-Up: The Rise of Digital Therapeutics (Part 2)
Published: 10/26/2024 -
October 2024 Datamonitor Healthcare Podcast: Insights from ESMO
Published: 10/21/2024 -
Scrip's Five Must-Know Things - 21 October 2024
Published: 10/21/2024 -
Drug Fix: SubQ Drugs And Price Negotiations, GLP-1s In Court, US FDA Approach To Black Box AI
Published: 10/18/2024 -
빅파마가 직면한 세포유전자 치료제 시장의 현실 (Korean-language podcast)
Published: 10/17/2024 -
China Biopharma Podcast - 16 October 2024 (Chinese language)
Published: 10/16/2024 -
Scrip's Five Must-Know Things - 15 October 2024
Published: 10/15/2024 -
Drug Fix: Inside Medicare Price Negotiations, New US FDA Vaccine Pathway
Published: 10/11/2024 -
Q&A Session on Psoriasis in Pediatric Patients with Dr. Valerie Welch
Published: 10/11/2024 -
COPD Treatment Strategies: Q&A with Dr. Kenneth Chinsky
Published: 10/11/2024 -
Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies
Published: 10/8/2024 -
Alpha-Synuclein Testing Comes of Age
Published: 10/4/2024 -
Q&A Session: PIK3CA Mutations and Breast Cancer
Published: 10/3/2024 -
Conference Catch-Up: LSX World Congress USA 2024
Published: 10/2/2024 -
The Future Of Drug R&D Is Self-Driving
Published: 9/30/2024 -
Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO
Published: 9/27/2024 -
Challenges in the Development and Manufacturing of ADCs
Published: 9/24/2024 -
September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up
Published: 9/19/2024
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.